Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, Moeckli R, Vozenin MC. Bourhis J, et al. Among authors: duclos f. Radiother Oncol. 2019 Oct;139:18-22. doi: 10.1016/j.radonc.2019.06.019. Epub 2019 Jul 11. Radiother Oncol. 2019. PMID: 31303340
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N, Ozsahin M, Zeverino M, Belmondo B, Durham AD, Lovis A, Simons J, Long O, Duclos F, Prior J, Denys A, Beigelman C, Sozzi WJ, Grant K, Gautier-Dechaud V, Peters S, Vienne M, Moeckli R, Bourhis J. Péguret N, et al. Among authors: duclos f. Radiother Oncol. 2016 Feb;118(2):220-6. doi: 10.1016/j.radonc.2015.10.011. Radiother Oncol. 2016. PMID: 26979264
Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.
Gaide O, Herrera F, Jeanneret Sozzi W, Gonçalves Jorge P, Kinj R, Bailat C, Duclos F, Bochud F, Germond JF, Gondré M, Boelhen T, Schiappacasse L, Ozsahin M, Moeckli R, Bourhis J. Gaide O, et al. Among authors: duclos f. Radiother Oncol. 2022 Sep;174:87-91. doi: 10.1016/j.radonc.2021.12.045. Epub 2022 Jan 5. Radiother Oncol. 2022. PMID: 34998899 Free article.
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M, Valerio M, Mampuya A, Rakauskas A, Berthold D, Tawadros T, Meuwly JY, Heym L, Duclos F, Vallet V, Zeverino M, Jichlinski P, Prior J, Roth B, Bourhis J, Herrera FG. Cloitre M, et al. Among authors: duclos f. Br J Radiol. 2023 Apr 1;96(1145):20220803. doi: 10.1259/bjr.20220803. Epub 2023 Mar 3. Br J Radiol. 2023. PMID: 36745031 Free PMC article. Clinical Trial.
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R, Gaide O, Jeanneret-Sozzi W, Dafni U, Viguet-Carrin S, Sagittario E, Kypriotou M, Chenal J, Duclos F, Hebeisen M, Falco T, Geyer R, Gonçalves Jorge P, Moeckli R, Bourhis J. Kinj R, et al. Among authors: duclos f. Clin Transl Radiat Oncol. 2024 Feb 8;45:100743. doi: 10.1016/j.ctro.2024.100743. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38362466 Free PMC article.
Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
Budiharto T, Musat E, Poortmans P, Hurkmans C, Monti A, Bar-Deroma R, Bernstein Z, Tienhoven Gv, Collette L, Duclos F, Davis B, Aird E; EORTC Radiation Oncology Group. Budiharto T, et al. Among authors: duclos f. Radiother Oncol. 2008 Sep;88(3):403-10. doi: 10.1016/j.radonc.2008.05.013. Epub 2008 Jun 4. Radiother Oncol. 2008. PMID: 18538427
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.
Matzinger O, Duclos F, van den Bergh A, Carrie C, Villà S, Kitsios P, Poortmans P, Sundar S, van der Steen-Banasik EM, Gulyban A, Collette L, Bolla M; EORTC Radiation Oncology Group. Matzinger O, et al. Among authors: duclos f. Eur J Cancer. 2009 Nov;45(16):2825-34. doi: 10.1016/j.ejca.2009.07.009. Epub 2009 Aug 12. Eur J Cancer. 2009. PMID: 19682889 Clinical Trial.
Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Hu CH, Neissel Valente MW, Halpern OS, Jusuf S, Khan JA, Locke GA, Duke GJ, Liu X, Duclos FJ, Wexler RR, Kick EK, Smallheer JM. Hu CH, et al. Among authors: duclos fj. Bioorg Med Chem Lett. 2021 Jun 15;42:128010. doi: 10.1016/j.bmcl.2021.128010. Epub 2021 Apr 1. Bioorg Med Chem Lett. 2021. PMID: 33811992
85 results